News

Access is key to building brand recognition and added value VANCOUVER, British Columbia, Jan. 02, 2020 Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based business focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to announce entry into a Memorandum...

Company goes from strength-to-strength with momentum into 2020 VANCOUVER, British Columbia, Dec. 30, 2019 — Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales is pleased to  extend, on behalf of its executive...

Second property includes acreage, permits and infrastructure with short timeline to production VANCOUVER, BC, — (December 17, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to announce...

Early reports already impacting decisions resulting in projected process efficiencies and cost savings VANCOUVER, BC, — (December 5, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to...

Approvals pave way for construction as scheduled VANCOUVER, BC, — (November 28, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has received the...

Preparation and planning key to rapid approval VANCOUVER, BC, — (November 21, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, is pleased to advise that it has submitted architectural,...

VANCOUVER, BC, — (GLOBE NEWSWIRE – November 15, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (FRA: A2PT0E) (formerly OTC: ATLED) (OTC: ISCNF) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both Israeli and European export sales, is pleased to announce that the Financial Industry Regulatory Authority,...

Expert Agronomic and Project Management Knowledge Vital to Early Success VANCOUVER, British Columbia, Nov. 14, 2019 (Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for both domestic and European export sales, has engaged the services of LinC by Growing...

VANCOUVER, BC, — (November 6, 2019) – Isracann Biosciences Inc.  (CSE: IPOT) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) has granted a total of 3,500,000 stock options to certain officers, directors, consultants and an investor relations provider of the Company pursuant to the Company’s stock option plan. The stock options may be exercised at a price...

Company engages respected contractors with Cannabis sector experience to ensure timely acceptance by government agencies VANCOUVER, British Columbia, Nov. 05, 2019 — Isracann Biosciences Inc. (CSE: IPOT) formerly Atlas Blockchain Group Inc. (CSE: AKE) (XFRA: A2PT0E) (OTC: ATLED) (the “Company”) an Israel-based company focused on becoming a premier low cost, high quality cannabis producer for...